BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34036437)

  • 1. Villoglandular adenocarcinoma of the uterine cervix: a systematic review and meta-analysis.
    Dietl AK; Beckmann MW; Aumann K
    Arch Gynecol Obstet; 2021 Aug; 304(2):317-327. PubMed ID: 34036437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the ovarian preservation safe in young women with stages IB-IIA villoglandular adenocarcinoma of the uterine cervix?
    Ju UC; Kang WD; Kim SM
    J Gynecol Oncol; 2018 Jul; 29(4):e54. PubMed ID: 29770624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Villoglandular papillary adenocarcinoma of the uterine cervix.
    Collinet P; Prolongeau JF; Vaneecloo S
    Eur J Obstet Gynecol Reprod Biol; 1999 Sep; 86(1):101-3. PubMed ID: 10471150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Villoglandular adenocarcinoma of the cervix: clarity is needed on the histological definition for this difficult diagnosis.
    Macdonald RD; Kirwan J; Hayat K; Herrington CS; Shawki H
    Gynecol Oncol; 2006 Jan; 100(1):192-4. PubMed ID: 16266744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Handling of Early-stage Cervical Cancer: A Literature Analysis of Villoglandular Adenocarcinoma of the Cervix.
    Dietl A; Aumann K; Beckmann MW
    Anticancer Res; 2020 Jun; 40(6):3049-3053. PubMed ID: 32487598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Villoglandular papillary adenocarcinoma of the uterine cervix: a diagnostic challenge.
    Korach J; Machtinger R; Perri T; Vicus D; Segal J; Fridman E; Ben-Baruch G
    Acta Obstet Gynecol Scand; 2009; 88(3):355-8. PubMed ID: 19172445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Villoglandular adenocarcinoma of the cervix: a report of three cases and review of the literature.
    Stanley-Christian H; Heim BK; Hines JF; Hall KL; Willett GD; Barnes WA
    Gynecol Oncol; 1997 Aug; 66(2):327-30. PubMed ID: 9264585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Villoglandular papillary adenocarcinoma of the cervix: case report.
    Lakhtakia R; Singh MK; Taneja P; Kapila K; Kumar S
    J Surg Oncol; 2000 Aug; 74(4):297-9. PubMed ID: 10962465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
    Poynor EA; Barakat RR; Hoskins WJ
    Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservative therapy in microinvasive adenocarcinoma of the uterine cervix is justified: an analysis of 59 cases and a review of the literature.
    Baalbergen A; Smedts F; Helmerhorst TJ
    Int J Gynecol Cancer; 2011 Dec; 21(9):1640-5. PubMed ID: 21897274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Villoglandular adenocarcinoma of the cervix uteri. A case report and analysis of the literature].
    Wiesenfeld U; Baraggino E; Melato M
    Minerva Ginecol; 1997 May; 49(5):221-4. PubMed ID: 9304084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors influencing decisions about surgical treatment of villoglandular adenocarcinoma of the uterine cervix.
    Kim HJ; Sung JH; Lee E; Ahn S; Song SY; Choi CH; Kim TJ; Kim BG; Bae DS; Lee JW
    Int J Gynecol Cancer; 2014 Sep; 24(7):1299-305. PubMed ID: 24987921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Villoglandular adenocarcinoma of cervix--a tumour with bland cytological features: report of a case missed on cytology.
    Jayaram G; Razak A
    Malays J Pathol; 2003 Dec; 25(2):139-43. PubMed ID: 16196371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Well-differentiated papillary villoglandular adenocarcinoma of the uterine cervix: a case report.
    Lu FH; Chen BF; Yang YC
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jul; 61(7):436-40. PubMed ID: 9699398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservative treatment of microinvasive adenocarcinoma of uterine cervix: long-term follow-up.
    Sopracordevole F; Canzonieri V; Giorda G; De Piero G; Lucia E; Campagnutta E
    J Low Genit Tract Dis; 2012 Oct; 16(4):381-6. PubMed ID: 22302130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervix.
    Huang ZY; Zhang S; Zhang YZ; An JH; Luo J; Liao PJ; Chen Q; Shen H
    Indian J Pathol Microbiol; 2018; 61(4):549-552. PubMed ID: 30303146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Retrospective Study and Literature Review of Cervical Villoglandular Adenocarcinoma: A Candidate Paradigm of Silva System Pattern A.
    Zhang Y; Wang Y; Liu Y; Yang J; Liu C
    Appl Immunohistochem Mol Morphol; 2021 Jul; 29(6):467-472. PubMed ID: 33337634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Villoglandular adenocarcinoma of the cervix: a case report.
    Hurteau JA; Rodriguez GC; Kay HH; Bentley RC; Clarke-Pearson D
    Obstet Gynecol; 1995 May; 85(5 Pt 2):906-8. PubMed ID: 7724158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery.
    Bean LM; Ward KK; Plaxe SC; McHale MT
    Am J Obstet Gynecol; 2017 Sep; 217(3):332.e1-332.e6. PubMed ID: 28522318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative Conization and Risk of Recurrence in Patients Undergoing Laparoscopic Radical Hysterectomy for Early Stage Cervical Cancer: A Multicenter Study.
    Casarin J; Bogani G; Papadia A; Ditto A; Pinelli C; Garzon S; Donadello N; Laganà AS; Cromi A; Mueller M; Raspagliesi F; Ghezzi F
    J Minim Invasive Gynecol; 2021 Jan; 28(1):117-123. PubMed ID: 32320800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.